Upload Avatar (500 x 500)
Xianrong Qi
qixr@bjmu.edu.cn
Chinese, Japanese, English
Beijing
Peking University
Pharmaceutical Sciences
  • 1993.6-1997.3 Ph.D. in Pharmacy: Hoshi University, Japan
  • 1982.9-1987.7 Bachelor's Degree in Science: Beijing Medical University
  • 2007.8-present - Peking University School of Pharmaceutical Sciences - Professor
  • 1998.7-2007.7 - Peking University School of Pharmaceutical Sciences - Associate Professor
  • 1993.6-1997.6 - Hoshi University, Japan - Visiting Researcher
  • 1993.7-1998.7 - Beijing Medical University School of Pharmacy - Lecturer
  • 1987.8-1993.7 - Beijing Medical University School of Pharmacy - Assistant
  • 2016: Peking University School of Pharmaceutical Sciences Teaching Excellence Award
  • 2016: Peking University Health Science Center Zhongwai Teaching Fund Award
  • 2015: Peking University Health Science Center Invention Patent Award
  • 2014: China Formulation Conference Excellent Paper First Prize (Student: Wang Aiting)
  • 2014: Peking University Excellent Doctoral Dissertation Supervisor (Doctoral Student: Yang Zhenzhen)
  • 2014: Peking University Health Science Center Undergraduate Innovation Experiment Project First Prize (Student: Pang Ning)
  • 2014: Peking University Outstanding Communist Party Member
  • 2013: Peking University Excellent Doctoral Dissertation Supervisor (Doctoral Student: Gao Wei)
  • 2012: Peking University Health Science Center SCI Paper Citation Award
  • 2012: Ministry of Education 'Higher Education Science and Technology Award' - Natural Science First Prize (5/10 Certificate No. 2012-002)
  • 2011: Honorary Professor, University of Hong Kong (2011.1.1-2013.12.31)
  • 2010: Peking University Outstanding Communist Party Member
  • 2009: Higher Education Natural Science First Prize (5/9)
  • 2008: Peking University School of Pharmaceutical Sciences Outstanding Communist Party Member
  • 2008: Honorary Professor, University of Hong Kong (2008.1.1-2010.12.31)
  • 2007: China Association of Integrative Medicine Science and Technology First Prize (5/17 Certificate No. 20078601A)
  • 2007: Acta Pharmaceutica Sinica Excellent Paper Award
  • 2003: Ministry of Education Science and Technology Progress Second Prize (3/10 Certificate No. 2003-049)
  • 2002: China Pharmaceutical Association Excellent Paper First Prize
  • 2001: Beijing Science and Technology Progress Third Prize (1/4 Certificate No. 2001-药-3-007-1)
  • 2000: China Higher Education Science and Technology Progress Second Prize (2/3 Certificate No. 2000-64)
  • 1999: China Pharmaceutical Association Excellent Paper Second Prize
  • 1998: Fourth Peking University International Exchange Paper Third Prize
  • 1996: Beijing Medical University Teaching Excellence Award
  • 1996: Nagai International Foundation Publication Award
  • 1995: National Education Commission Science and Technology Progress Second Prize (7th Contributor Certificate No. 95-189)
Construction, targeted design, and evaluation of drug delivery systems
Nanotechnology and biotechnology
  • Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy, Yang, Zhen-zhen; Gao, Wei; Liu, Yu-jie; Pang, Ning; Qi, Xian-rong, 2017
  • Taming the Wildness of 'Trojan-Horse' Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents, Shi, Nian-Qiu; Qi, Xian-Rong, 2017
  • Treating metastatic triple negative breast cancer with CD44 neuropilin dual molecular targets of multifunctional nanoparticles, De-Sheng Liang, Wen-Jie Zhang, Ai-Ting Wang, Hai-Tao Su, Hai-Jun Zhong, Xian-Rong Qi, 2017
  • Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation, Yu-Jie Liu, Ying-Cong Ma, Wen-Jie Zhang, Zhen-Zhen Yang, De-Sheng Liang, Zhi-Fu Wu, Xian-Rong Qi, 2017
  • Intestinal absorption and neuroprotective effects of kaempferol-3-O-rutinoside, Yingcong Ma, Yujie Liu, Aning Sun, Yitian Du, Min Ye, Xiaoping Pu, Xianrong Qi, 2017
  • Characterization of amphiphilic dendrimer modified PEG-PLA nanoparticles prepared by a double emulsion-solvent evaporation method, Xin Li, Ning Pang, Ji Li, Xianrong Qi, 2017
  • Preparation, characterization and pharmacokinetics of 10-hydroxycamptothecin nanosuspension, Yi Zhang, Ying Zhan, Ning Pang, Yujie Liu, Shixuan Cheng, Ji Li, Yitian Du, Xianrong Qi, 2017
  • Synthetic low-density lipoprotein (sLDL) selectively delivery paclitaxel to tumor with low systemic toxicity, Hai-Tao Su, Xin Li, De-Sheng Liang, Xian-Rong Qi, 2016
  • Tumor-specific penetrating peptides-functionalized hyaluronic acid-d-α-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers, D.S. Liang, H.T. Su, Y.J. Liu, A.T. Wang, X.R. Qi, 2015
  • Targeting and microenvironment responsive lipid nanocarrier for the enhancement of Targeting and Microenvironment-Responsive Lipid Nanocarrier for the Enhancement of Tumor Cell Recognition and Therapeutic Efficiency, W. Gao, T. Meng, N. Shi, H. Zhuang, Z. Yang, X.R. Qi, 2015
  • Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors, A. Wang, D. Liang, Y. Liu, X.R. Qi, 2015
  • Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer, D. Dong, W. Gao, Y. Liu, X.R. Qi, 2015
  • Tumor specific delivery with redox-1 triggered mesoporous silica nanoparticles inducing neovascularization suppression and vascular normalization, L. Sun, Y.J. Liu, Z.Z. Yang, X.R. Qi, 2015
  • Enhance Cancer Cell Recognition and Overcome Drug Resistance Using Hyaluronic Acid and α-Tocopheryl Succinate Based Multifunctional Nanoparticles, D.S. Liang, H.T. Su, Y.J Liu, A.T. Wang, X.R. Qi, 2015
  • Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas, Z.Z. Yang, J.Q. Li, Z.Z. Wang, D.W. Dong, X.R. Qi, 2014
  • Dual receptor-specific peptides modified liposomes as VEGF siRNA vector for tumor-targeting therapy, Z. Yang, B. Xiang, D. Dong
Drug Delivery Targeted Design Evaluation Nanotechnology Biotechnology Systems Construction Mechanisms Therapeutics Biomedical

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.